David S. Leake
Reading, ENG RG66UR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Inhibition of Low-Density Lipoprotein Oxidation by Cysteamine, Cystamine, Cysteine and Cystine at Lysosomal pH and pH 7.4.
Journal: Antioxidants (Basel, Switzerland)
Published: October 17, 2025
Early Behavioral Markers of Loss of Financial Capacity.
Journal: JAMA network open
Published: June 13, 2025
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection.
Journal: Innate immunity
Published: March 04, 2025
Bridging the SME reporting gap: A new model for predicting Scope 1 and 2 emissions.
Journal: Journal of industrial ecology
Published: January 01, 2025
Low density lipoprotein oxidized under lysosomal conditions decreases arterial vasodilatation.
Journal: Free radical research
Published: September 13, 2024
Estimating carbon footprints from large scale financial transaction data.
Journal: Journal of industrial ecology
Published: January 01, 2023
Monocytic Cell Adhesion to Oxidised Ligands: Relevance to Cardiovascular Disease.
Journal: Biomedicines
Published: November 03, 2022
Effects of lysosomal low-density lipoprotein oxidation by ferritin on macrophage function.
Journal: Free radical research
Published: October 11, 2022
Workplace inequality is associated with status-signaling expenditure.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 08, 2022
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice.
Journal: Journal of the American Heart Association
Published: September 08, 2021
Vitamins E and C do not effectively inhibit low density lipoprotein oxidation by ferritin at lysosomal pH.
Journal: Free radical research
Published: August 16, 2021
Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment.
Journal: Frontiers in immunology
Published: May 28, 2021
Last Updated: 09/26/2026